China has a large and well-established pharmaceutical research, manufacturing, and supply system, making it an important participant in the global pharmaceutical supply chain. For overseas importers, pharmaceutical distributors, wholesalers, and procurement companies, sourcing from China…
What are the most common targeted cancer drugs? Common targeted cancer drugs include therapies targeting EGFR, ALK, HER2, KRAS, BRAF, VEGF/VEGFR, PARP, and CDK4 The appropriate treatment depends on the cancer type, molecular target, biomarkers,…
What are the most common chemotherapy drugs? Common chemotherapy drugs include Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Gemcitabine, Pemetrexed, Fluorouracil (5-FU), Capecitabine, and Irinotecan. Chemotherapy is one of the most important treatment options for cancer. It…
Ovarian cancer drugs in China mainly include five categories: PARP inhibitors, anti-angiogenic therapies, antibody-drug conjugates (ADCs), PD-1 immunotherapy, and chemotherapy, covering first-line treatment, maintenance therapy, recurrent disease, and platinum-resistant ovarian cancer. Ovarian cancer is one…
What are the treatment options for Duchenne muscular dystrophy? Current treatment options for Duchenne muscular dystrophy include corticosteroids, exon-skipping therapies, gene therapy, rehabilitation, and supportive care. Treatment is individualized based on the patient’s age, disease…
Cancer treatment is often a long and uncertain journey. Global pharmaceutical distributor DengYueMed has organized the 10 key questions cancer patients ask to help patients better understand cancer treatment pathways and make more informed decisions…
In 2024, several new lung cancer treatments, including Unecritinib Fumarate Capsules, Tarlatamab, Zenocutuzumab, Lazertinib and Amivantamab Combination, and Durvalumab, were approved, offering groundbreaking options for patients with various types of lung cancer. Drug Name Brand…
